Cite
HARVARD Citation
Testa, A. et al. (2023). Dual Pathway Inhibition of Coagulation and Inflammation With Rivaroxaban: A New Therapy Paradigm Against Atherosclerosis. Journal of cardiovascular pharmacology. 81 (2), pp. 117-119. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Testa, A. et al. (2023). Dual Pathway Inhibition of Coagulation and Inflammation With Rivaroxaban: A New Therapy Paradigm Against Atherosclerosis. Journal of cardiovascular pharmacology. 81 (2), pp. 117-119. [Online].